4.2K
Downloads
72
Episodes
The Stock2Me Podcast is your source for the latest news and updates on market trends and movers in high-profile industry sectors. We’ll keep you in the loop regarding the companies on our watchlist and provide in-depth information about the inner workings and eccentricities of the ever-evolving North American markets. https://www.stock2me.com
Episodes
![Stock2Me Podcast featuring AzurRx Biopharma Inc. President & CEO James Sapirstein [Video Edition]](https://pbcdn1.podbean.com/imglogo/image-logo/7657459/Stock2Me-cover_300x300.jpg){kind=logo}
Tuesday Nov 24, 2020
Tuesday Nov 24, 2020
The Stock2Me Podcast features a fascinating array of companies and individuals, many of whom are actively revolutionizing age-old business practices within their respective markets. Stock2Me’s latest podcast features James Sapirstein, President & CEO of AzurRx BioPharma Inc. (NASDAQ: AZRX).
AzurRx currently has two ongoing clinical trials for MS1819. The first is a Phase 2 Cystic Fibrosis Combination Trial examining MS1819 in combination with PERT, which is expected to produce topline data in Q2 2021.